5634 results about "W o emulsion" patented technology

The present invention generally relates to systems and methods to create stable emulsions with low rates of exchange of molecules between microdroplets.

System, including methods, apparatus, compositions, and kits, for making and using compound droplets of a multiple emulsion to supply an amplification reagent, such as a heat-stable DNA polymerase or DNA ligase, to an aqueous phase in which the compound droplets are disposed. The compound droplets may be induced to supply the amplification reagent by heating the multiple emulsion, to achieve hot-start amplification.

The present invention provides a foamable composition for administration to the skin, body surface, body cavity or mucosal surface, e.g., the mucosa of the nose, mouth, eye, ear, respiratory system, vagina or rectum. The foamable oil in water emulsion composition includes: an oil globule system, selected from the group consisting of oil bodies; and sub-micron oil globules, about 0.1% to about 5% by weight of an agent, selected from the group consisting of a surface-active agent, having an HLB value between 9 and 16; and a polymeric agent, and a liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition, water and optional ingredients are added to complete the total mass to 100%. Upon release from an aerosol container, the foamable composition forms and expanded foam suitable for topical administration.

System, including methods, apparatus, compositions, and kits, for making and using a stabilized emulsion. A method of generating a stabilized emulsion is provided. In the method, an aqueous phase may be provided. The aqueous phase may include an effective concentration of one or more skin-forming proteins. An emulsion may be formed. The emulsion may include droplets of a dispersed phase disposed in a continuous phase, with the aqueous phase being the continuous phase or the dispersed phase. The emulsion may be heated to create an interfacial skin between each droplet and the continuous phase, to transform the droplets into capsules.

The present invention relates to oil-in-water mascara compositions comprising water-insoluble polymeric materials in the form of an aqueous emulsion, water-soluble, film-forming polymers and organophilic clays. Said compositions exhibit improved wear and are removable with soap and water.

The invention discloses aqueous fire-proof corrosion-proof paint for a steel structure and a preparation method thereof, and belongs to the technical field of paint. The aqueous fire-proof corrosion-proof paint comprises, by mass, 20-45% of a composite emulsion, 12-25% of a charring catalyst, 6-12% of a foaming agent, 8-17% of a charring agent, 5-10% of a fire retardant, 1-5% of layered double hydroxide, 8-18% of an corrosion-proof filling material, 4-12% of a strengthening filling material, 1-5% of modified nano-powder, 0.5-6% of an assistant and 10-30% of water. Through use of the composite modified emulsion as a base material, coating flame resistance, corrosion resistance and decorativeness are obtained and coating defects caused by a single emulsion as a base material are overcome. Through use of a small amount of the nano-powder, the coating is compact because of filling effects of the nano-powder, the coating corrosion caused by O2, H2O and Cl <-> is avoided, good fire-proof and corrosion-proof effects are obtained under the condition of a small addition amount and a cost is reduced. The aqueous fire-proof corrosion-proof paint has the characteristics of green environmental protection and simple preparation processes.

A polypropylene type aqueous dispersion comprising the following components (a) to (c):

wherein the component (a) has a main chain having the following features (1) and (2) and dispersion particles in the dispersion have an average particle size of at most 0.5 μm,

Feature (1) when observing a peak derived from a carbon atom of a methyl group in a propylene unit chain part comprising a head-to-tail bond by ¹³C-NMR and fixing a chemical shift of a peak top at a peak attributable to pentad expressed by mmmm to 21.8 ppm, a ratio (S₁/S) of an area S₁ of a peak of a peak top at 21.8 ppm to a total area S of peaks at from 19.8 ppm to 22.1 ppm is at least 10% and at most 60%, and when an area of a peak (mmmr) of a peak top at 21.5 to 21.6 ppm is expressed as S₂, 4+2S₁/S₂>5, and Feature (2) a content ratio (mol ratio) of propylene unit (A): other olefin unit (B) is from 100:0 to 90:10.

The present invention relates to an oil-in-water emulsion topical delivery system comprising an oil phase; an aqueous phase; phenoxyethanol; an effective exfoliatingamount of a hydrophobic hydroxycarboxylic acid; a non-ionic emulsifier having an HLB of from about 7 to about 10; and at least one skin-supporting ordermatopharmaceutically active agent.

The present invention is directed to seamless capsules and methods for making seamless capsules having a high oil content. More specifically, the present invention is directed to seamless capsules, and methods for making seamless capsules, made from a process involving the steps of: (a) preparing an emulsion comprising oil, water, an emulsifier, and at least one of a water-soluble monovalent metal salt, polyvalent metal salt, and an acid, wherein said oil is present in an amount of at least 50% by weight of said emulsion; with the proviso that said emulsion does not contain marmelo mucilage; and (b) adding portions of said emulsion to an aqueous gelling bath comprised of at least one ionic polysaccharide, thereby encapsulating said portions of said emulsion in a polysaccharide gel membrane, and optionally (c) drying the resulting capsules by removing water. The capsule is, for example, an alignate gel. The capsules of the invention are suitable for a variety of applications, e.g. pharmaceutical, nutraceutical, veterinay, agricultural, cosmetic, or food applications.

This invention generally relates to cationic oil-in-water emulsions that can be used to deliver negatively charged molecules, such as an RNA molecule. The emulsion particles comprise an oil core and a cationic lipid. The cationic lipid can interact with the negatively charged molecule thereby anchoring the molecule to the emulsion particles. The cationic emulsions described herein are particularly suitable for delivering nucleic acid molecules (such as an RNA molecule encoding an antigen) to cells and formulating nucleic acid-based vaccines.

Gelled emulsions contain (i.) an external phase of an aqueous water-soluble solvent solution, polymeric viscosifying agent and, optionally, an oxidative and/or acidic breaker; and (ii.) an internal phase of a dispersed organic fluid. The aqueous water-soluble solvent solution constitutes between from about 15 to about 50 volume percent of the gelled emulsion and the dispersed organic fluid is presented in the gelled emulsion in amounts ranging from about 50 to about 85 volume percent. The gelled emulsions are useful in a variety of applications including, but not limited to, oil field, pipeline and processing facility applications.

Liquid aqueous and nonaqueous textile-cleaning compositions containing particles of a fuzz-reducing component selected from the group consisting of: a) biological polymers, b) hydrogels, c) synthetic polymers and d) silicone emulsions, wherein not less than 90% of the particles of a fuzz-reducing components a), b) or c) have a particle size of less than 100 μm, and wherein a fuzz-reducing component selected from d) has an average droplet size below 50 μm.

A reactor produces a gas-in-liquid emulsion for providing increased interfacial contact area between the liquid and the gas for improved reaction of the gas with the liquid, or more rapid solution or reaction of a difficulty soluble or immiscible gas in or with a liquid. The reactor is suitable for a continuous or batch type process. Rotor and stator cylindrical members are mounted for rotation relative to one another and have opposing surfaces spaced to form an annular processing passage. The gap distance between the opposing surfaces and the relative rotation rate of the cylindrical members are such as to form a gas-in-liquid emulsion of the gas in the liquid. The liquid and gas pass through the processing passage, changing into the gas-in-liquid emulsion.

A method for delivering a High Internal Phase Emulsion to a substrate. The method includes providing a rotating roll, The rotating roll has a central longitudinal axis, wherein the rotating roll rotates about the central longitudinal axis, an exterior surface defining an interior region and substantially surrounding the central longitudinal axis, and a vascular network configured for transporting the one or more fluids in a predetermined path from the interior region to the exterior surface of the rotating roll. The method further includes providing a High Internal Phase Emulsion to the rotating roll vascular network. The method further includes contacting a substrate with the rotating roll and contacting the substrate with the High Internal Phase Emulsion.

Tocopherol-modified therapeutic drug compounds; emulsion, microemulsion, and micelle formulations that include the compounds; methods for making the compounds and formulations; methods for administering the compounds and formulations; and methods for treating conditions using the compounds and formulations.

A vinyl polymer having at least one terminal group of the general formula (1) per molecule;

—OC(O)C(R)═CH₂  (1)

wherein R represents hydrogen or an organic group containing 1 to 20 carbon atoms;

• • a curable composition containing said polymer;
  • an aqueous emulsion containing either said polymer or said curable composition;
  • a pressure sensitive adhesive composition and a pressure sensitive adhesive each comprising said curable composition or aqueous emulsion.

A treatment fluid for use in a combined acidizing and proppant fracturing treatment, the treatment fluid comprising: (A) an emulsion comprising: (i) a continuous oil phase; (ii) an internal aqueous phase comprising: (a) water; and (b) a source of an acid; and (iii) an emulsifier; and (B) a proppant. A method of fracturing a treatment zone of a well, the method comprising the steps of: (I) forming a treatment fluid according to the invention; and (II) introducing the treatment fluid into the zone at a rate and pressure greater than the fracture gradient of the zone.

The invention provides a microfluidic device and a method for preparing microgel by using the microfluidic device. The method comprises the steps of (1) taking a solution containing live cells or bioactive molecules, a photocuring agent and a hydrogel prepolymer as an internal phase, taking a mixed solution containing oil and an surfactant as an intermediate phase, and taking a polyvinyl alcohol aqueous solution as an external phase; (2) respectively conveying the internal phase, the intermediate phase and the external phase into a corresponding microchannel of the microfluidic device through a micro pump or a micro injector to form a monodispersed water-in-oil-in-water double emulsion; (3) enabling the monodispersed water-in-oil-in-water double emulsion in the step (2) to pass through an output channel of the microfluidic device, and collecting the monodispersed water-in-oil-in-water double emulsion in the step (2) into a collection vessel filled with an aqueous solution, thus obtaining the microgel immobilizing with the live cells or the bioactive molecules. The preparation of the microgel immobilizing with cells by a one-step method is realized, the obtained microgel is controllable in size, and narrow in size distribution, and meanwhile the survival rate of cells is maintained.

New emulsion and micelle formulations are described as are complexes of these formulations with biologically active substances. The novel formulations are different from cationic lipid vectors such as cationic liposomes in that the complexes formed between biologically active substances and the emulsion and micellar formulations of this invention are physically stable and their transfection activity is resistant to the presence of serum. These novel formulations are disclosed to be useful in areas such as gene therapy or vaccine delivery.

The invention provides a fluorine-silicon modified self-crosslinking acrylic ester emulsion and a preparation method thereof, belonging to the technical field of polymer synthesis. The emulsion is a product formed by organosilicon monomers, fluoride-containing acrylic monomers, (methyl) acrylic monomers and self-crosslinking monomers through core-shell emulsion polymerization. The preparation method adopts a core-shell emulsion polymerization method, thereby ensuring that the fluoride-containing acrylic monomers tend to surface polymerization, and fluorine atoms tend to polymer surface in emulsion film forming process; moreover, the monomers capable of self-crosslinking is added to a shell layer, so as to utilize the crosslinking of the monomers to fixedly limit the migration of the fluorine atoms towards the inside of latex particles, as well as the swing of chains, thereby ensuring that the performances of the fluoride-containing emulsion are completely embodied. The preparation method improves the water resistance, stain resistance, solvent resistance, weather resistance and other comprehensive performances of the emulsion. The fluorine-silicon modified self-crosslinking acrylic ester emulsion prepared through the preparation method can be widely applied to high-grade building paint, industrial paint and wooden ware varnish. Moreover, the preparation method has the characteristics of simple manufacturing process, easy reaction condition control, good emulsion stability and environment-friendly property.

The apparatus and methods of the present invention are of use for the production of emulsion-based microparticles containing a biological or chemical agent. In particular, the apparatus provides a vessel; packing material situated inside such vessel and may further provide material capable of insertion into both ends of said vessel for enclosure of the packing material. In a particular embodiment, the apparatus is a packed bed apparatus. The methods include production of emulsion based microparticles containing a biological or chemical agent. The usefulness of the present invention is that the apparatus and methods of the present invention provide for a low-shear, non-turbulent, production of emulsion-based microparticles that provides a narrow, reproducible, particle size distribution, capable of use with both large and small volumes that is capable of being conveniently scaled up while providing predictable emulsion properties.